Bio-Techne - RnD Systems, CELLXVIVO HUMAN MONOCYTE-DERIVED DC DIFFERENTIATION KIT (1 KIT), CDK004
Bio-Techne Corporation -- Item TECPIM000602481
Please add to cart & request for quote to see the price
Reserve Now
CellXVivo Human Monocyte-derived DC Differentiation Kit (1 kit, CDK004) is a complete reagent set for the differentiation of human CD14+ monocytes into immature and mature dendritic cells for ex vivo research. The kit provides serum-free dendritic cell base media plus recombinant human IL-4, GM-CSF and TNF-α and includes reagents and buffers required to generate immature dendritic cells in 7 days and to induce maturation with TNF-α for downstream immunological assays. It is intended for generating monocyte-derived dendritic cells for phenotypic analysis and functional assays.
Key Features:
- Quantity: 1 kit (Catalog/Part: CDK004)
- Species: Human
- Reagents supplied: Serum-Free Dendritic Cell Base Media, Recombinant Human IL-4, Recombinant Human GM-CSF, Recombinant Human TNF-α, Reconstitution Buffer 2
- Typical differentiation protocol: 1 x 10^6 CD14+ cells/mL cultured for 7 days; maturation induced with TNF-α for 3 days
- Storage: unopened kit at -20 to -70 °C; opened/reconstituted components 2–8 °C (short term) or -20 to -70 °C (long term)
Advantages:
- Provides optimized, validated reagents to reproducibly generate immature and mature monocyte-derived dendritic cells
- Straightforward procedures that do not require specialized instrumentation
- Includes serum-free base media and key recombinant cytokines for controlled differentiation and maturation
Product Details
Overview
| Model | |
|---|---|
| Product Type | Consumables |
| Part Number | CDK004 |
| Brand | Bio-Techne Corporation |
| Gross Dimensions (WxDxH cm) | |
| Net Dimensions (WxDxH cm) | |
| Gross Weight (kg) | |
| Net Weight (kg) | 0.5 |
Specifications
More options are available. Please contact us for more information.
Document
More options are available. Please contact us for more information.
Videos
More options are available. Please contact us for more information.